PartnershipsEvent: September 3, 2026
Charles River Laboratories announced a collaboration with Medigen Vaccine Biologics Corp. to support the development of its next-generation multivalent enterovirus vaccine using Charles River's advanced NGS and biologics testing capabilities.
Published
Signal category
Partnerships
Quote
“We're excited to collaborate with Medigen Vaccine Biologics Corp. to support the development of its next-generation multivalent enterovirus vaccine using Charles River's advanced NGS and biologics testing capabilities.”
— David Russell|Charles River Laboratories team
Company
Charles River Laboratories
Together, We Create Healthier Lives
- Industry
- Biotechnology Research
- Location
- Wilmington, US
- Company size
- 14,354 employees
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Founded 1947